First- and second-trimester evaluation of risk (faster) trial: principal results of the NICHD multicenter down syndrome screening study - 29/08/11
Doi : 10.1016/j.ajog.2003.10.001
Fergal D Malone 1, Nicholas J Wald 2, Jacob A Canick 3, Robert H Ball 4, David A Nyberg 5, Christine H Comstock 6, Radek Bukowski 7, Richard L Berkowitz 8, Susan J Gross 9, Lorraine Dugoff 10, Sabrina D Craigo 11, Ilan E Timor 12, Stephen R Carr 3, Honor M Wolfe 13, Kimberly A Dukes 14, Diana W Bianchi 11, Alicja Rudnicka 2, Allan Hackshaw 2, Geralyn Lambert-Messerlian 3, Mary E D'Alton 1
1 Columbia University, New York, NY, USA
2 Wolfson Institute of Preventive Medicine, London, United Kingdom
3 Brown University, Providence, RI, USA
4 University of Utah, Salt Lake City, UT, USA
5 Swedish Medical Center, Seattle, WA, USA
6 William Beaumont Medical Center, Royal Oak, MI, USA
7 University of Texas Medical Branch, Galveston, TX, USA
8 Mount Sinai Medical Center, New York, NY, USA
9 Albert Einstein College of Medicine, New York, NY, USA
10 University of Colorado Health Sciences Center, Denver, CO, USA
11 Tufts University, Boston, MA, USA
12 New York University, New York, NY, USA
13 UNC Medical Center, Chapel Hill, NC, USA
14 DM-STAT, Boston, MA, USA
Vol 189 - N° 6S
P. S56 - décembre 2003 Retour au numéro
Article précédent
- Oral Plenary Session I
- Fetoscopic laser surgery versus serial amniodrainage in the management of severe twin-to-twin transfusion syndrome at midgestation. a randomized controlled trial
- Marie-Victoire Senat, Jan Deprest, Michel Boulvain, Yves Ville
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?